A previous study demonstrated that the HO-1 level in human osteoarthritis (OA) cartilages from type 2 diabetes mellitus (T2DM) after CoPP treatment was significantly lower than those from non-T2DM (Vaamonde-Garcia et al. 2017). The gene discussed is HMOX1; the disease is type 2 diabetes mellitus.